Hypertriglyceridemia
📧 Sign up to get email alerts when something new happens for Hypertriglyceridemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-01-28FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for fenofibric acid submitted by Amneal Pharmaceuticals of New York LLC.
-
FDA label_change · 2013-01-18FDA Approved: LIPOFEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for LIPOFEN (fenofibrate) submitted by ANI Pharmaceuticals, Inc., resulting in changes to the drug's…
-
FDA approval · 2012-12-19FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for Fenofibrate, updating the product labeling and/or approvals under a sup…
-
FDA approval · 2012-12-07FDA Approved: FENOFIBRATE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approves Mylan's original ANDA for fenofibrate, enabling the marketing of a generic fenofibrate product.
-
CLINICAL_TRIALS trial_result · 2012-10-30Clinical Trial Update: Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy [NA]
A completed clinical trial evaluated the effect of tenofovir disoproxil fumarate on lipid levels in HIV-infected adults on stable antiretrov…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-10-19FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved Amneal Pharmaceuticals NY LLC’s supplemental application for fenofibrate, authorizing the generic product's approval.
-
FDA approval · 2012-09-05FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for fenofibric acid from Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2012-08-31FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for Lovaza (omega-3-acid ethyl esters), enabling changes to its labeling as requested by Waylis …
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol ("Bad Cholesterol") and Triglycerides [Phase 3]
Phase 3 safety and efficacy trial comparing ABT-143 to simvastatin in individuals with dyslipidemia, hypercholesterolemia, and hypertriglyce…
-
FDA approval · 2012-07-26FDA Approved: VASCEPA — Original Application (Amarin Pharma Inc.)
FDA approved Vascepa (icosapent ethyl) under its Original Application for use in adults with severe hypertriglyceridemia to reduce triglycer…
-
CLINICAL_TRIALS trial_result · 2012-06-21Clinical Trial Update: Crocus Sativus (Saffron) and Berberis Vulgaris (Barberry Fruit) in Metabolic Syndrome [Phase 4]
Phase 4 clinical trial evaluating saffron (Crocus sativus) and barberry fruit extract (Berberis vulgaris) in metabolic syndrome and related …
-
CLINICAL_TRIALS trial_result · 2012-04-18Clinical Trial Update: Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects [Phase 4]
Phase 4 trial evaluating boosted Lexiva (fosamprenavir) with Lovaza adjunctive therapy in HIV-infected patients with hypertriglyceridemia. R…
-
CLINICAL_TRIALS research · 2012-04-13Clinical Trial Update: Postprandial Lipid Metabolism in Familial Hypercholesterolaemia:Effects of Fish Oils [NA]
This is a Clinical Trial Update exploring the effects of fish oils on postprandial lipid metabolism in individuals with familial hypercholes…
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: Intervention With n3 LC-PUFA-supplemented Yogurt [NA]
A completed clinical trial evaluated n3 LC-PUFA–supplemented yogurt in moderately hypertriglyceridemic subjects.
-
FDA approval · 2012-03-01FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' supplemental application for fenofibrate.
-
FDA approval · 2012-03-01FDA Approved: FENOFIBRATE — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's original application (ANDA090859) for a generic fenofibrate product, authorizing its marketi…
-
FDA approval · 2012-02-07FDA Approved: FENOFIBRATE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
The FDA approved a supplemental application for fenofibrate from Rhodes Pharmaceuticals L.P., authorizing changes to the product under an ex…
-
CLINICAL_TRIALS research · 2011-11-29Clinical Trial Update: Fish Oil Supplementation and Vascular Function in Hypertensive Patients With Hypertriglyceridemia [Phase 4]
This is a Phase 4 clinical trial update examining the effects of fish oil supplementation on vascular function in hypertensive patients with…
-
CLINICAL_TRIALS research · 2011-11-24Clinical Trial Update: Efficacy Study to Treat Subjects With Severe Hypertriglyceridemia [Phase 3]
An update on a Phase 3 efficacy study for severe hypertriglyceridemia sponsored by Trygg Pharma, Inc., with the trial's status currently unk…
-
CLINICAL_TRIALS trial_result · 2011-11-18Clinical Trial Update: The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes [NA]
This clinical trial update reports on the triglyceride-lowering effect observed when adding docosahexaenoic acid (DHA) to statin therapy in …
-
CLINICAL_TRIALS trial_result · 2011-11-15Clinical Trial Update: Laparoscopic Adjustable Gastric Banding With Truncal Vagotomy [NA]
The clinical trial of laparoscopic adjustable gastric banding with truncal vagotomy was terminated, and the update notes the status without …
-
CLINICAL_TRIALS trial_result · 2011-09-22Clinical Trial Update: Changes in Blood Lipids After Long-term Consumption of n-3 LC-PUFA-Enriched Dairy Products [NA]
This completed clinical trial assesses how long-term consumption of omega-3 LC-PUFA-enriched dairy products influences blood lipid levels in…
-
FDA approval · 2011-09-19FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for Lovaza (omega-3-acid ethyl esters) submitted by Waylis Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2011-09-02Clinical Trial Update: Effect of Changing Diet on Fasting and Post Fat Load Lipoproteins [NA]
A completed clinical trial evaluated the effect of dietary changes on fasting and post-fat-load lipoproteins. The study enrolled individuals…
-
FDA approval · 2011-06-27FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved a supplemental application for fenofibrate from Amneal Pharmaceuticals NY LLC under the ANDA. The approval confirms changes…